Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1997-09-08
2000-08-22
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
264 41, 264 43, A61K 9127
Patent
active
061068586
ABSTRACT:
Disclosed is a method for making liposomes, for example multivesicular liposomes (MVLs), containing one or more biologically active agents, wherein the loading of the active agents into the liposomes is modulated by adjusting the osmolarity of the aqueous component into which the agents are dissolved prior to encapsulation. To increase the loading of the active agent, the osmolarity of the aqueous component is reduced, and to decrease the loading of the active agent, the osmolarity of the aqueous component is increased. In the making of MVLs, the process involves dissolving the active agent and an optional osmotic excipient in a first aqueous component encapsulated within the liposomes. For any given concentration of drug, the osmolarity of the first aqueous component can be adjusted by increasing or decreasing the concentration or molecular weight of the osmotic excipients used therein. The rate of release of the active agent into the surrounding environment in which the liposomes are introduced can be simultaneously controlled by incorporating into the lipid component used in the formulation at least one long chain amphipathic lipid. For example, the amphipathic lipid can have from about 13 to about 28 carbons in its carbon chain. Use of the long chain amphipathic lipid in the lipid component is particularly helpful in controlling the release rate and encapsulation efficiency for high drug load formulations.
REFERENCES:
patent: Re35192 (1996-03-01), Reese
patent: 5049392 (1991-09-01), Weiner
patent: 5077056 (1991-12-01), Bally et al.
patent: 5091187 (1992-02-01), Hayes
patent: 5204112 (1993-04-01), Hope et al.
patent: 5211955 (1993-05-01), Legros et al.
patent: 5227165 (1993-07-01), Domb et al.
patent: 5227170 (1993-07-01), Sullivan
patent: 5244678 (1993-09-01), Legros et al.
patent: 5246707 (1993-09-01), Haynes
patent: 5261903 (1993-11-01), Dhaliwal et al.
patent: 5321012 (1994-06-01), Mayer et al.
patent: 5334381 (1994-08-01), Unger
patent: 5334391 (1994-08-01), Clark et al.
patent: 5451408 (1995-09-01), Mezei et al.
Shakiba, et al., "Evaluation of Retinal Toxicity and Liposome Encapsulation of the Anti-CMV Drug 2'-nor-cyclic CMP," Investigative Opthalmology and Visual Science, No. 10, 34:2903-2910, Sep. 1993.
Frucht-Perry, et al., "Fibrin-Enmeshed Tobramycin Liposomes: Single Application Topical Therapy of . . . ," Cornea, No. 5, 11:393-397, Sep. 1992.
Assil, et al., "Tobramycin Liposomes. Single Subconjunctival Therapy of . . . ," Investigative Opthalmology and Visual Science, No. 13, 32:3216-3220, Dec. 1991.
Assil, et al., "Liposome Suppression of Proliferatative Vitreoretinopathy. Rabbit . . . ," Investigative Opthalmology and Visual Science, No. 11, 32:2891-2897, Oct. 1991.
Turski, et al., "Magnetic Resonance Imaging of Rabbit Brain After Intracarotid Injection . . . ," Magnetic Resonance in Medicine, No. 2, 7:184-196, Jun. 1996.
Skuta et al., "Filtering Surgery in Owl Monkeys Treated With the Antimetabolite . . . ," American Journal of Opthalmology, No. 5, 103:714-716, May 15, 1987.
Assil, et al., "Multivascular Liposomes. Sustained Release of the Antimetabolite . . . ," Archives of Opthalmology, No. 3, 105:400-403, Mar., 1987.
Barbet, et al., "Weak Acid-Induced Release of Liposome-Encapsulated Carboxyfluorescein," Biochimica et Biophysica Acta, No. 3, 772:347-356, May 30, 1984.
Kim, et al., "Preparation of Cell-Size Unilamellar Liposomes with High Captured Volume and Defined Size . . . ," Biochim. Biophys. Acta, 646:1-9, 1981.
Kim, et al., "Preparation of Multivesicular Liposomes," Biochim. Biophys. Acta, 728: 339-348, 1983.
Kim, et al., "Preparation of Multialmellar Vesicles of Defined Size-Distribution by Solvent-Spherule . . . ," Biochim. Biophys. Acta, 812: 793-801, 1985.
Kim, et al., "Multivesicular Liposomes Containing Cytarabine Entrapped in the Presence of . . . ," Cancer Treat. Rep., 71: 705-711, 1987.
Kim, et al., "Multivescular Liposomes Containing Cytosine 1-.beta.-D-Arabinofuranosylcytosine for Slow-Release Intrathecal Therapy," Cancer Research, 47: 3935-3937, 1987.
Kim, et al., "Multivesicular Liposomes Containing Cytosine for Slow Release . . . ," Cancer Treat. Rep., 71: 447-450 1987.
Kim, et al., "Modulation of the Peritoneal Clearance of Liposomal Cytosine Arabinoside by . . . ," Cancer Chemother. Pharmacology, 19:307-310, 1987.
Roy, et al., "Multivesicular Liposomes Containing Blemomycin for Subcutaneous Administration," Cancer Chemother. Pharmacology, 28: 105-108, 1991.
Kim, et al., "Prolongation of Drug Exposure in Cerebrospinal Fluid by Encapsulation Into . . . ," Camcer Research Pharmacology, 55: 1596-1598, Apr. 1, 1993.
Kim, et al., "Driect Cerebrospinal Fluid Delivery of an Antiretroviral Agent Using . . . ," Jrnl. Of Infectious Diseases., 162: 750-752, 1990.
Chamberlain, et al., "Treatmentof Leptomeningeal Metastasis with Intraventricular Administration of . . . ," Archives of Neurol., 50: 261-264, 1993.
Chatelut, et al., "A Slow-Release Methotrexate Formulation for Intrathecal Chemotherapy," Cancer Chemother. Pharmacol., 32:179-182, 1993.
Russack, et al., "Quantitative Cerebrospinal-Fluid Cytology in Patients Receiving Intracavitary Chemotherapy," Ann. Neurol., 34:108-112, 1993.
Kim, et al., "Extended Cerebrospinal-Fluid Cytarabine Exposure Folling Intrathecal Administration of DTC 101," J. Clin. Oncol., 11:2186-2193, 1993.
Kim, "Liposomes as Carriers of Cancer Chemotherapy: A Review," Drugs, No. 4, 46:618-638, 1993.
Kim, et al., "Extended-Release Formulation of Morphine for Subcutaneous Administration," Cancer Chemother. Pharmacol., 33:187-190, 1993.
Ishii, "Production and Size Control of Large Unilamellar Liposomes by Emulisification," Liposome Technology, 1:111-121, 1993.
Cullis, et al., "Structural Properties and Functional Roles of Phospholipids In . . . ," Phospholipids and Cellular Regulation, 1:65-123, 1985.
Bonetti, et al., "An Extended-Release Formulation of Methotrexate For Subcutaneous . . . " Cancer Chemotherapy and Pharmacology, In Press, 1994.
Grunor, et al., "Novel Multilayered Lipid Vesicles: Comparison of Physical Characteristics of Multilamellar Liposomes and Stable Plurilamellar Vesicles," Biochemistry, No. 12, 24:2833-2842, Jun. 4, 1985.
Narhi, etal., "Role of Native Disulfide Bonds in the Structure and Activity of Insulin-like Growth Factor 1: Genetic Models of Protein-Folding Intermediates," Biochemistry, No. 19:5214-5221, 1993.
Katre Nandini
Sankaram Mantripragada
Ye Qiang
Kishore Gollamudi S.
SkyePharma Inc.
LandOfFree
Modulation of drug loading in multivescular liposomes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of drug loading in multivescular liposomes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of drug loading in multivescular liposomes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-577718